Skip to main content

Right Heart Catheterization

Performing right heart caths

Right heart catheterization—or right heart cath—is the only test that can confirm a pulmonary arterial hypertension (PAH) diagnosis. In contrast to right heart echoes, right heart caths provide direct measurements of key hemodynamic parameters and pressures and, when used over time, can track a patient's disease progression and treatment responses.1

Normalizing hemodynamics and improving right heart size and structure are critical to ensuring optimal long-term outcomes in your patients with PAH. Monitoring and understanding these hemodynamic parameters helps ensure optimal treatment outcomes by proactively adjusting therapies when a patient hasn’t sufficiently improved.2

Video icon

Review the methodology of a right heart cath for diagnosis and monitoring of PAH

Watch Short Video

Key hemodynamic parameters

Pulmonary artery pressure (PAP), pulmonary arterial wedge pressure (PAWP), and signals of right ventricular (RV) dysfunction measured by right heart cath provide critically important prognostic information about your patient’s disease status. These measurements should be done at diagnosis and periodically during follow-up over the course of treatment.1-5

Additional hemodynamic parameters that provide a comprehensive view of the right heart include:

BNP/NT-proBNP

CI

CO

mPAP

PVR

RVSP

Right heart cath is required for diagnosis and baseline data1

Right heart cath is the only test that can confirm a PAH diagnosis. When clinical tests and echo imaging indicate a suspicion of PH, right heart cath is required to confirm diagnosis. Data from the right heart cath at diagnosis help differentiate which form of PH a patient may have and help guide selection of the initial treatment regimen.1

Right heart cath is needed to confirm PAH

Many clinical indicators can increase the likelihood that your patient may have PAH, including signs and symptoms, lab tests, and a virtual echocardiography screening tool (VEST) score derived from echo imaging data. Any of these results may lead you to request a right heart cath for your patient to confirm a PAH diagnosis.6

Based on today’s guidelines, confirmation of PAH is when a patient has1:

  • mPAP >20 mm Hg
  • PAWP ≤15 mm Hg
  • PVR ≥2 WU
Right heart catheterization diagram showing PAWP, PVR, and mPAP values

Review the diagnostic algorithm based on current guidelines and recommendations

Download Diagnostic Algorithm

Baseline right heart cath data inform treatment plans

The pressure readings and hemodynamic data gathered from right heart cath can be used to complete a formal risk calculation for patients diagnosed with PAH. Today’s treatment guidelines use the baseline risk score as the primary input to determine the combination of medications used in the initial treatment regimen.2

Right heart cath for clinical monitoring for PAH

Right heart pressures are critical in diagnosing and setting initial treatment plans and can be helpful in monitoring your patients’ right heart function once they are on therapy. The current 2022 ESC/ERS Treatment Guidelines recommend more frequent evaluations: right heart cath should be ordered in cases of clinical worsening and can be used for follow-up 3 to 6 months after changes in therapy.1

Right heart cath evaluations can show patient improvement and responses to treatments. They can also reveal any hemodynamic worsening, serving as a trigger to escalate treatment to help your patient’s long-term outcomes.1

Video icon

Learn how key hemodynamic parameters help determine patient disease status and treatment response

Watch Short Video

Hemodynamics from right heart cath are prognostic

The 2022 ESC/ERS Treatment Guidelines–based risk strata are among the many registries representing real-world data captured from thousands of patients across global registries and clinical practice. These data are reliable predictors of how well your patient is doing.1,3,8-10 Because hemodynamic variables provide prognostic data, they are embedded in these risk calculation tools, such as the REVEAL 2.0 or 2022 ESC/ERS calculator. Managing PAH with these validated, real-world parameters helps clinicians navigate the complexities of PAH and choose the combination treatment regimen that is appropriate for their patients’ disease status.1,2

Risk of 1-year mortality from 2022 ESC/ERS Treatment Guidelines1

Risk of 1-year mortality from 2022 ESC/ERS Treatment Guidelines Columns show low, intermediate, and high 1-year mortality risk ranges for RAP, CI, SVI, and SvO2 values.

 

Low risk
<5%

Intermediate risk
5%-20%

High risk
>20%

RAP
<8 mm Hg
8-14 mm Hg
>14 mm Hg
CI
≥2.5 L/min/m2
2.0-2.4 L/min/m2
<2.0 L/min/m2
SVI
>38 mL/m2
31-38 mL/m2
<31 mL/m2
SvO2
>65%
60%-65%
<60%

Normal right heart cath pressures have clinical significance

Understanding key right heart cath pressures is essential because they provide a definitive assessment of hemodynamic function and strain. These measurements allow clinicians to accurately stratify patient risk and tailor treatment decisions. When hemodynamic parameters remain elevated or worsen despite current therapy, escalating treatment by adding agents that target additional pathways should be considered to improve hemodynamic function and prevent disease progression.1

Parameters to manage PAH

Parameter

Normal values

Clinical significance

Measured parameters

RAP1,11

2-6 mm Hg

Reflects RV preload & degree of right heart venous congestion

RVSP12

15-30 mm Hg

Represents peak pressure generated by RV during systole

mPAP1,12,13

8-20 mm Hg

Represents average pressure in PA throughout cardiac cycle

sPAP1,14

15-30 mm Hg

Represents peak pressure during RV systole

dPAP1,14

4-12 mm Hg

Reflects residual pressure during diastole

PCWP14

6-12 mm Hg

Indirectly estimates LAP & LV filling pressure; differentiates precapillary from postcapillary PH

CO1,15

4-8 L/min

Reflects total volume of blood pumped per minute

SvO21,2

65%-80%

Measures overall oxygen status; in PAH, low SvO2 is associated with declining RV function

Calculated parameters

CI1

2.5-4.0 L/min·m2

Reflects right heart function; CI = CO / BSA

PVR1,2

≤2 WU

Reflects RV afterload & burden on RV function

Get the Right Heart Cath Quick Reference

Download Right Heart Cath Parameters

Right heart cath: A routine procedure critical to patient management

You can help patients understand the importance of securing accurate information to establish a proper diagnosis and treatment plan.

The PAH Initiative has developed a patient education brochure to help you explain the RH cath procedure. This information may help you align expectations and provide patients with a clear understanding of what to expect during the procedure.

Where can my patients get a right heart cath?

If you do not have a relationship with clinicians who conduct right heart caths or are looking for right heart cath facilities, the CHEST PH Expert Center Finder is a helpful resource to explore. Below is a link that helps you locate providers near you who can perform right heart caths. CHEST is a global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care.

Connect With a PH Expert in Your Area

Learn more about medications that may help improve right heart parameters in PAH

Explore PAH Therapy

Right heart imaging is key to diagnosing and monitoring PAH

Explore Key Right Heart Videos
BNP=B-type natriuretic peptide; BSA=body surface area; CHEST=American College of Chest Physicians; CI=cardiac index; CO=cardiac output; dPAP=diastolic pulmonary arterial pressure; echo=echocardiography; ERS=European Respiratory Society; ESC=European Society of Cardiology; LAP=left atrial pressure; LV=left ventricle/left ventricular; mPAP=mean pulmonary arterial pressure; NT-proBNP=N-terminal pro–B-type natriuretic peptide; PCWP=pulmonary capillary wedge pressure; PH=pulmonary hypertension; PVR=pulmonary vascular resistance; RAP=right atrial pressure; REVEAL=Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management; RV=right ventricle/right ventricular; RVSP=right ventricular systolic pressure; sPAP=systolic pulmonary arterial pressure; SVI=stroke volume index; SvO2=mixed venous oxygen saturation; WU=Wood unit.
References: 1. Humbert M, et al. Eur Heart J. 2022;43(38):3618-3731. 2. Dardi F, et al. Eur Respir J. 2024;64(4):2401323. 3. Benza RL, et al. Chest. 2019;156(2):323-337. 4. Kia DS, et al. Front Physiol. 2021;12:641310. 5. Kovacs G, et al. Eur Respir J. 2024;64(4):2401324. 6. Vaidya A, et al. Pulm Circ. 2020;10(3):1-10. 7. Galiè N, et al. Eur Heart J. 2016;37(1):67-119. 8. Kylhammar D, et al. Eur Heart J. 2018;39(47):4175-4181. 9. Hoeper MM, et al. Eur Respir J. 2017;50(2):1700740. 10. Boucly A, et al. Eur Respir J. 2017;50(2):1700889. 11. Ryan JJ, et al. Can J Cardiol. 2015;31(4):391-406. 12. Haleem SM, Chaudhari SS. Right heart cardiac catheterization. In: StatPearls [Internet]. Updated July 5, 2025. Accessed June 22, 2026. https://pubmed.ncbi.nlm.nih.gov/32491336/ 13. Rosenkranz S, Preston IR. Eur Respir Rev. 2015;24(138):642-652. 14. Del Rio-Pertuz G, et al. Am J Cardiovasc Dis. 2023;13(3):122-137. 15. King J, Lowery DR. Physiology, cardiac output. In: StatPearls [Internet]. Updated July 17, 2023. Accessed June 22, 2026. https://www.ncbi.nlm.nih.gov/books/NBK470455/

Going to CHEST?

Can first-year treatment decisions really change PAH outcomes?

Hear experts explore the data

The Clinical Challenge: How Important Is the First Year of PAH Therapy?

Monday, October 19, 2026

2:30 ᴘᴍ–3:15 ᴘᴍ

Phoenix Convention Center

Learning Theater 3

Hear 4 PAH experts explore key considerations in patient care today:

  • Why low risk matters
  • How early action can help improve outcomes
  • How frequent risk assessments and right heart evaluations can inform treatment decisions